When is Regard the better choice?

It recommends diagnoses from the full record rather than assembling it, on the premise that clinicians see a fraction of the chart, and writes the note around the recommendation. The oversight gate is structural, with the clinician accepting or declining each recommendation and the vendor reporting how often they do. Interoperability is certified rather than claimed, with named deployments and quantified site level results.

When is Zus Health the better choice?

It assembles the longitudinal record in the first place, pulling from thousands of provider sites, prescription fills and admission alerts and normalising the result. It publishes its match rate rather than implying identity resolution is solved, and links every summarised point to the underlying record. It is a platform other products build on, with distinct access routes for care teams, developers and analytics.

Regard vs Zus Health

Last VerifiedAugust 4, 2026

Verdict

These are two steps in one pipeline and buying them out of order is the mistake worth avoiding. Zus assembles the record, pulling from thousands of provider sites, prescription fills and admission alerts, normalising it and publishing a match rate that admits identity resolution is imperfect. Regard reads the assembled chart and recommends diagnoses, writing the note around them, with a structural gate where the clinician accepts or declines each one and certified interoperability behind it. A diagnostic recommendation generated from an incomplete chart is confident reasoning from a partial picture, and neither vendor publishes how complete the record is at the moment the recommendation is made. If your outside records arrive sparsely, fix that before adding a system that draws conclusions from what did arrive.

Select Regard if

It recommends diagnoses from the full record rather than assembling it, on the premise that clinicians see a fraction of the chart, and writes the note around the recommendation.
The oversight gate is structural, with the clinician accepting or declining each recommendation and the vendor reporting how often they do.
Interoperability is certified rather than claimed, with named deployments and quantified site level results.

Select Zus Health if

It assembles the longitudinal record in the first place, pulling from thousands of provider sites, prescription fills and admission alerts and normalising the result.
It publishes its match rate rather than implying identity resolution is solved, and links every summarised point to the underlying record.
It is a platform other products build on, with distinct access routes for care teams, developers and analytics.

Attribute Matrix

Side by Side

Axis	R Regard	Z Zus Health
AI Centrality
Autonomy and Oversight Model
Model and Technology Transparency
Clinical and Operational Evidence
AI Safety and PHI Stewardship
HIPAA and BAA Posture
Security Certifications and Trust Center
FDA and Regulatory Status
AI Governance and Bias Disclosure
EHR and Interoperability Depth
Deployment Model and Data Residency
Commercial Transparency
Setting and Specialty Coverage

Keep Comparing

Related comparisons

Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Summarization & Chart Review page.

Abstractive Health vs Regard→Abstractive Health vs Zus Health→Credo Health vs Regard→Credo Health vs Zus Health→emtelligent vs Zus Health→Evidently vs Regard→Fourier Health vs Regard→Particle Health vs Zus Health→Pieces vs Regard→Regard vs Wellsheet→ThetaRho vs Zus Health→

Disclosure

The sequencing point matters clinically here: a system that recommends diagnoses from an incomplete chart is confidently reasoning from a partial picture, and neither vendor publishes what proportion of records are missing at the moment a recommendation is generated. Regard publishes no accuracy figure, model card or validation publication, and its certification examines record system criteria rather than diagnostic performance. Zus publishes no security attestation. Neither publishes what proportion of surfaced findings prove clinically actionable.